The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
The Scientist
Most Recent
A new journal that publishes peer review comments alongside its manuscripts goes live.
A study suggests that some mouse models do not accurately mimic human molecular mechanisms of inflammatory response, but other mouse strains may fare better.
Why so few scientists make the leap to policy-making positions, and why more should give it a try
Protein aggregates in the brains of some people with dementia or motor neuron disease have a surprising origin.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
Globally, 15-year-old girls outscored boys in 43 of the 65 countries tested.
One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.
In Chapter 1, “A Theory,” author Aaron James constructs a working definition for the type of person that earns the ignominious moniker.
Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
